Sfoglia per AUTORE
MOLTENI A
Collezione ASL Biella

  

Items : 3

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "old-fashioned" Drug be Effective? in HemaSphere

2023
ASL Biella

Riva M; Bosi A; Rizzo L; Mazzon F; Ferrari S; Lussana F; Borin L; Castelli A; Cairoli R; Barcellini W; Molteni A; Fattizzo B;

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS) in Blood

2022
ASL Torino 4
ASL Biella

Lanino L; Salutari P; Perego A; Fattizzo B; Riva M; Ubezio M; Musto P; Cilloni D; Oliva EN; Voso MT; Pelizzari AM; Poloni A; Capodanno I; Elena C; Fozza C; Pane F; Breccia M; De Gobbi M; Di Bassiano F; Barraco D; Crisà E; Ferrero D; Frairia C; Vaccarino A; Griguolo D; Paolini S; Quintini M; Sessa M; Turrini M; et alii...

Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study in Blood

2022
ASL Biella

Bosi A; Fattizzo B; Rizzo L; Ferrari S; Lussana F; Borin LM; Castelli A; Bianchi P; Barcellini W; Cairoli R; Molteni A; Riva M;